When you visit the White Coats Foundation website one of the first things you see is the quote “The future depends on what we do in the present” – Mahatma Ghandi. We love this because it emphasises the power of now and that nothing changes unless we do. It’s empowering, inclusive and motivating and that’s what we want to inspire in the communities we reach out to.
Our mission is to support the discovery of better health through awareness. We want to acknowledge the individuals that play a vital role in enabling the advancement of medical science and access to new and improved therapeutic interventions which have the potential to benefit any one of us.
We are pleased and grateful to announce that joining us on this journey, as a WCF ambassador, is Michelle Gallaher. As a healthy volunteer for a year-long Ebola vaccine trial and a vocal advocate for the value of clinical trials in our healthcare system, Michelle is well known and recognised as a champion and spokesperson. She is a leader, influencer, collaborator and mentor …..and importantly she wears a White Coat!
Michelle Gallaher – CEO, ShareRoot (ASX:SRO)
Michelle Gallaher has been an entrepreneur, allied health clinician, advocate and leader in the Australian life sciences and health sector for over 25 years.
Michelle is best known for her role as a champion of the Victorian biotechnology industry and in advocating for women in science, technology, engineering, mathematics and medicine (STEMM). She has sponsored, championed and mentored many in the technology, biotechnology and medtech start-up community, particularly women.
Her career spans allied health clinician, pharmaceutical marketing and product development, through to executive roles in biotech companies and major national research initiatives. Most recently Michelle has served the Victorian biotech industry as Chief Executive Officer of the peak body for biotechnology and medtech in Victoria, the BioMelbourne Network.
Leaving corporate life in 2014, Michelle established The Social Science, a unique digital communication, technology and content agency focused on the science, health, engineering and technology sector. Michelle successfully sold The Social Science to US-based ShareRoot in 2018, a marketing technology developer. Ten months post acquisition, Michelle was promoted to the CEO role of ShareRoot and is in the process of bringing the business to Australia, realigning the technology development pipeline to be predominantly health focussed.
Michelle is also co-founder of a not-for-profit advocacy group, Women in STEMM Australia and leads the organisation’s advocacy agenda and media liaison, speaking at events in Australia and overseas to drive great gender equality and equity for women.
Michelle currently serves as a non-executive director on the boards of Cancer Trials Australia, The Actuator, Springboard Australia (lifesciences advisory) and the development committee for the Australian Regenerative Medicine Institute. Michelle is also on the Board of Directors for Praxis Australia .
A sought-after speaker, mentor, advocate, collaborator and influencer, Michelle is particularly passionate about the importance of social media in healthcare, digital health, data ethics and data rights, clinical trials, artificial intelligence, the emerging importance of real word data in science and health, as well as the pivotal role of women in STEMM industries. Michelle is a committed contributor to the Victorian community as an Ambassador for the Victoria Against Violence Campaign, an Ambassador for White Coats Foundation and a regular at the St Vincent de Paul’s CEO Sleep Out in Melbourne.
Michelle was awarded the Victorian Telstra Business Woman of the Year 2017 and the Victorian Entrepreneur of the Year 2017 and was inducted into the Victorian Honour Roll for Women in 2018. Michelle was also named as a finalist in the Australian Small Business Awards Entrepreneur of the Year 2018 and the Social Science was the winner of a Westpac 200 Business of Tomorrow award in June 2018. Michelle is a Fellow of the Australian Institute for Management and a Graduate of the Institute for Company Directors and is in the last few months of a Global Executive MBA specialising in lifesciences and data transformation.